EUVIMEDEUVIMED entdecken
Systematische Übersicht

Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review

Fernanda Cristina de Abreu Quintela-Castro iD, Taísa Sabrina Silva Pereira iD, Danúbia Boy Alves iD, Letícia Chiepe iD, Laura Sperandio Nascimento iD, Kelly Cristina Mota Braga Chiepe iD, Rafael Mazioli Barcelos iD, Bruno Maia Costa iD, Oscar Geovanny Enriquez-Martinez iD, Joamyr Victor Rossoni iD, Tatiani Bellettini-Santos iD

Nutrition Reviews · 2023

DOI: 10.1093/nutrit/nuad003 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, 2023. Verfasst von Fernanda Cristina de Abreu Quintela-Castro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program of Research and Extension (CEPEG), University Center of Espirito Santo, Colatina, Espirito Santo, Brazil. Hauptthemen laut MEDLINE: Transgender Persons, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil, Fundação de Amparo à Pesquisa e Inovação do Espírito Santo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

A recent US national survey of the health status of the male transgender population has raised awareness about the little-studied relationship between testosterone hormone therapy in transgender men and cardiovascular outcomes.

Objective

The aim of this systematic review was to assess the relationship between cross-sex hormone therapy in transgender men and lipid profiles and cardiovascular risk. Data Sources The PubMed, SciELO, SpringerLink, and EBSCOhost databases were searched up to March 2021 for studies assessing the association between cross-sex hormone therapy and the incidence of outcomes related to cardiovascular disease in transgender men over 18 years of age . Data Extraction Data extracted were sorted into clinical data (systolic, diastolic, and mean blood pressure), anthropometric data (body mass index, weight, waist circumference, fat mass, and lean mass), and biochemical data (triglycerides, total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], very low-density lipoprotein cholesterol [VLDL-C], and the HDL-C to LDL-C ratio). Data Analysis Study quality was appraised independently by two reviewers using the Cochrane tools for assessment of methodological quality or risk of bias in nonrandomized studies, and the Newcastle-Ottawa Scale was applied. Of 735 studies identified, 11 were included in the review. Most studies reported no change in cholesterol or triglyceride levels after hormone treatment. A reduction in HDL-C levels was observed in 7 of 11 studies, although this alone cannot be considered a cardiovascular risk factor. Likewise, clinical and anthropometric findings showed no changes predictive of cardiovascular risk.

Conclusions

Although these findings suggest that hormone therapy may lead to a decrease in HDL-C levels and an increase in LDL-C levels, they are insufficient to establish a relationship with cardiovascular disease. Furthermore, no significant effects on metabolic and anthropometric values were found. Further studies with higher quality and longer follow-up periods are needed to establish cardiovascular risk. Systematic Review Registration PROSPERO registration number CRD 42020212560.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsCardiovascular DiseasesHumansMaleAdultAdolescentCholesterol, LDLCholesterolTriglyceridesCholesterol, HDLGonadal Steroid HormonesRisk FactorsFemale

Stichwörter der Autor:innen

cardiovascular risktestosteronetransgender

Substanzen

Cholesterol, LDLCholesterolTriglyceridesCholesterol, HDLGonadal Steroid Hormones

Autor:innen und Institutionen

  • Graduate Program of Research and Extension (CEPEG), University Center of Espirito Santo, Colatina, Espirito Santo, Brazil.
  • Department of Health Sciences, Universidad de las Americas Puebla (UDLAP), Puebla, Mexico.
  • Department of Health, Multivix College São Mateus, São Mateus, Espirito Santo, Brazil.
  • Graduate Program in Public Health, Federal University of Espírito Santo (UFES), Vitória, Espirito Santo, Brazil.

ORCID-Profile: Fernanda Cristina de Abreu Quintela-Castro, Taísa Sabrina Silva Pereira, Danúbia Boy Alves, Letícia Chiepe, Laura Sperandio Nascimento, Kelly Cristina Mota Braga Chiepe, Rafael Mazioli Barcelos, Bruno Maia Costa, Oscar Geovanny Enriquez-Martinez, Joamyr Victor Rossoni, Tatiani Bellettini-Santos

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brasil
  • Fundação de Amparo à Pesquisa e Inovação do Espírito Santo

Zitieren

APA

Quintela-Castro, F. C. A., Pereira, T. S. S., Alves, D. B., Chiepe, L., Nascimento, L. S., Chiepe, K. C. M. B., Barcelos, R. M., Costa, B. M., Enriquez-Martinez, O. G., Rossoni, J. V., & Bellettini-Santos, T. (2023). Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuad003

Vancouver

Quintela-Castro FCA, Pereira TSS, Alves DB, Chiepe L, Nascimento LS, Chiepe KCMB, et al. Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review. Nutrition Reviews. 2023. doi:10.1093/nutrit/nuad003

BibTeX
@article{QuintelaCastro2023,
  author = {Quintela-Castro, Fernanda Cristina de Abreu and Pereira, Taísa Sabrina Silva and Alves, Danúbia Boy and Chiepe, Letícia and Nascimento, Laura Sperandio and Chiepe, Kelly Cristina Mota Braga and Barcelos, Rafael Mazioli and Costa, Bruno Maia and Enriquez-Martinez, Oscar Geovanny and Rossoni, Joamyr Victor and Bellettini-Santos, Tatiani},
  title = {Lipid profile and risk of cardiovascular disease in adult transgender men receiving cross-sex hormone therapy: a systematic review},
  journal = {Nutrition Reviews},
  year = {2023},
  doi = {10.1093/nutrit/nuad003}
}
Kostenlos starten →